P PRIMESTOCKFINDER.COM

PNV Shares PolyNovo Limited

ASX · ASX
$0.85 -3.98% Prices as of close 2026-10-26

Last in our picks 2026-10-26 — not in the current list; analysis below is from that screen

High-growth wound-care adoption and expanding hospital penetration support attractive revenue momentum.

Future value: $1.25 (+48.06%) · 6-12 months · analyst consensus

  • ▸Product adoption and positive growth momentum.
  • ▾Below 50-day MA (-12.75%)
  • ▸Volume 1.94× average — accumulation
  • ▾Near 52-week low (6.1% of range)
  • ▸~48% upside to price target

Trend: PNV is trading below the 50-day average (-11.98%), RSI 50 — neutral momentum, with a 3-month return of +0.00%.

Valuation & quality: PolyNovo Limited trades on a trailing P/E of 84.5, forward P/E 31.0, PEG 1.53, price-to-book 6.45; fundamentals show net margin 4.9%, return on equity 8.4%, revenue growth 15.0% year on year.

Analyst consensus: 7 analysts have a mean 12-month price target of A$1.25 (+48.4% vs the last close; range A$0.95 – A$1.70), consensus rating “buy”.

Our screen: BUY (score 3) — High-growth wound-care adoption and expanding hospital penetration support attractive revenue momentum.

Computed from end-of-day data; not personal advice.

Our simulated $10,000 funds have traded PNV 1 time — 0 of 1 closed trade profitable.

FundBoughtSoldReturn
ASX High-risk2026-08-28 @ $1.042026-09-01 @ $1.00 · Monthly rebalance-3.85%

Paper trades from our simulated funds at real end-of-day prices; past results don't predict future returns.

1.27 0.81 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-08 → 2026-10-26 (AUD). Range 0.81 – 1.27.
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
+4.20%+0.00%+22.00%-24.60%-5.40%+14.90%-7.00%-8.60%
Market cap
$583.8M
P/E (ttm)
84.5
Forward P/E
31.0
EPS (ttm)
$0.01
Price / book
6.45
PEG
1.53
Beta
1.34
Net margin
4.9%
ROE
8.4%
Revenue growth
15.0%
Earnings growth
-25.7%
Revenue (ttm)
$149.8M
Free cash flow
$-1,822,000
Debt / equity
19%
52-wk range
$0.81 – $1.42
Volume
3,613,099
Avg volume (3m)
1,734,638
Mean target
$1.25
Low
$0.95
High
$1.70
Analysts
7
Consensus
BUY
RSI (14)
50.4
vs 50-day MA
-11.98%
1-mo return
-9.14%
3-mo return
+0.00%
Volume z-score
2.34

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China.

Sector: Healthcare · Industry: Medical Devices · Australia · Website

Browse: all ASX stocks · Health Care picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.